Although up-to-date knowledge regarding the relationship between cancer and TRPM5 is still poor, it has been linked to metabolic changes in the TME, potentially influencing tumor progression in metabolic disorders like diabetes-associated cancers [113,114,126]. Here, TRPM5 is linked to metabolic disease.